| 单词 | Vioxx |
| 例句 | Vioxx was linked to an increased risk of heart attacks by one meta-analysis; this was later confirmed with a randomized clinical trial. A Consumer's Guide To Medical Jargon 2010-08-23T10:00:00Z The prosecution asks how he can reconcile that opinion with the fact that Clemens once told “60 Minutes” that he would eat the anti-inflammatory Vioxx “like Skittles.” Asleep at the Roger Clemens trial 2012-06-10T13:00:00Z Inc. will pay $950 million to settle criminal and civil charges that it illegally promoted the painkiller Vioxx, the Justice Department announced Tuesday. Merck to pay almost $1B to settle Vioxx probe 2011-11-22T20:35:00Z In 2004, Merck volunteered to take the blockbuster pain medication Vioxx off the market when it discovered that the drug doubled patients’ risk of heart attacks and strokes. Abortion Ruling Could Undermine the F.D.A.’s Drug-Approval Authority 2023-04-10T04:00:00Z Its manufacturer, Merck & Company, claimed Vioxx could relieve arthritic pain without causing gastric ulcers — a potential side effect of non-steroidal anti-inflammatory drugs like ibuprofen and naproxen. Book review: A doctor’s impassioned critique of big pharma 2022-03-20T04:00:00Z In addition to Crump, the family is represented by the New York-based trial lawyer Christopher Seeger, who helped win billion-dollar settlements against such companies as Volkswagen and the producer of the painkiller Vioxx. Family of Henrietta Lacks hires civil rights attorney to seek funds over famous cells 2021-07-31T04:00:00Z In the wake of the Vioxx debacle, the FDA began requiring extensive cardiac monitoring during clinical trials, as well as extensive monitoring of drugs following approval. From the pandemic, a roadmap for lowering the costs of medicine 2021-03-31T04:00:00Z In the few short years since Vioxx was on the market, FDA scientists estimated it cost somewhere between 88,000 and 120,000 heart attacks. The art of scientific deception: How corporations use "mercenary science" to evade regulation 2020-02-02T05:00:00Z The bill, lawmakers said, was influenced by agency lapses in oversight of drugs like Vioxx, a popular painkiller withdrawn from the market in 2004 after it was found to pose a substantial heart risk. F.D.A. Failed to Ensure Safe Prescribing of Opioids, Documents Show 2019-12-30T05:00:00Z But Merck obscured the fact that Vioxx doubled the risk of heart attacks in patients without providing better pain relief. Book review: A doctor’s impassioned critique of big pharma 2022-03-20T04:00:00Z —Merck came under attack for excluding some heart attack cases from a paper on a clinical trial of its blockbuster pain reliever Vioxx. What’s in a name? Ghostly spirits stalk the medical literature 2019-11-10T05:00:00Z Another three reported increased risk of heart attacks and strokes from the painkiller Vioxx. Why Doctors Still Offer Treatments That May Not Help 2019-08-26T04:00:00Z It just doesn't apply in the case of vaccines – even though it is applicable with chemicals like PFOAs, and drugs like Vioxx. The art of scientific deception: How corporations use "mercenary science" to evade regulation 2020-02-02T05:00:00Z The company also withdrew Vioxx from the market. Oklahoma could provide first test of who will pay for the opioid crisis — and how much 2019-02-19T05:00:00Z Abramson writes that the FDA "failed" the family of one patient who took Vioxx by "not intervening in the unfolding public health emergency after its officers' reports, based on Merck's data, clearly identified the risks." Book review: A doctor’s impassioned critique of big pharma 2022-03-20T04:00:00Z But that rate is still higher than the cap in the Vioxx case. As Pelvic Mesh Settlements Near $8 Billion, Women Question Lawyers’ Fees 2019-02-01T05:00:00Z Not until 2002 did Merck add warning labels to the drug, at FDA's request; and not until 2004 did the company voluntarily withdraw Vioxx from the market after further studies showed serious cardiovascular risks. Expert witness David Egilman wins billions—and makes enemies—as he fights companies over public health 2019-01-24T05:00:00Z One of the things that defined your early years at Merck was the defense against lawsuits over Vioxx, a painkiller that posed heart risk and was pulled off the market. Merck C.E.O. Ken Frazier on Death Row Cases and the Corporate Soul 2018-03-09T05:00:00Z Sippy said the Vioxx name, no longer protected by trademark, might scare some people, while others would remember its effectiveness. APNewsbreak: Startup could bring back Vioxx for hemophilia 2017-11-21T05:00:00Z Examples like Vioxx are common in the industry, as Abramson repeatedly lays out. Book review: A doctor’s impassioned critique of big pharma 2022-03-20T04:00:00Z And in 2000, Merck disregarded its own studies showing substantial risk of heart attacks from the painkiller Vioxx and continued to market the drug for another four years. Analysis | Inside the call where CEOs found their moral compass and steered away from Trump 2017-08-18T04:00:00Z Egilman testified on behalf of the widow and daughter of a 56-year-old man who died of a heart attack after taking Vioxx. Expert witness David Egilman wins billions—and makes enemies—as he fights companies over public health 2019-01-24T05:00:00Z We did not want Vioxx to become a verbal shorthand, like an Enron or something of that nature, for corporate wrongdoing. Merck C.E.O. Ken Frazier on Death Row Cases and the Corporate Soul 2018-03-09T05:00:00Z Vioxx was so effective that some users hoarded it after Merck took it off market. APNewsbreak: Startup could bring back Vioxx for hemophilia 2017-11-21T05:00:00Z Merck also continued to pump cash into Vioxx, "spending more money to market a drug than any company in history," he notes. Book review: A doctor’s impassioned critique of big pharma 2022-03-20T04:00:00Z Ramsden testified the bags contained Toradol, Vicodin, the muscle relaxants Flexeril and cyclobenzaprine, Valium or Diazepam for back spasms, and prescription NSAIDs Indocin, Bextra and Vioxx. Ex-Seahawk fights team over painkiller handouts that kept him playing NFL games while hurt 2017-04-07T04:00:00Z In this case, Merck recruited 600 doctors to conduct a trial designed "to accelerate the uptake of Vioxx," according to an internal memo. Expert witness David Egilman wins billions—and makes enemies—as he fights companies over public health 2019-01-24T05:00:00Z Drug safety watchdogs point to examples like the painkiller Vioxx, which was withdrawn from the market in 2004 over safety concerns, as proof of the high stakes involved in drug approval. Trump’s F.D.A. Pick Could Undo Decades of Drug Safeguards 2017-02-05T05:00:00Z When it stopped making Vioxx, Merck was facing thousands of lawsuits from people claiming the drug caused their heart attacks or strokes. APNewsbreak: Startup could bring back Vioxx for hemophilia 2017-11-21T05:00:00Z Vioxx, made by Merck, and Celebrex, made by Pfizer, could quell pain and inflammation just as well as drugs like ibuprofen and naproxen, but they did not cause ulcers and gastrointestinal bleeding. Celebrex Is Found to Be No Riskier for Hearts Than Other Pain Drugs 2016-11-13T05:00:00Z Vioxx and Bextra became blockbusters because they avoided this problem, but heart concerns emerged and the drugs were withdrawn. 3 arthritis pain drugs prove equally safe for the heart 2016-11-13T05:00:00Z In a rebuttal letter to the journal, a Merck scientist said the study was a "double-blind, randomized, controlled clinical trial with a legitimate scientific purpose" in testing how well patients tolerated Vioxx. Expert witness David Egilman wins billions—and makes enemies—as he fights companies over public health 2019-01-24T05:00:00Z The concern was triggered in 2004 when Merck & Co. was forced to pull its COX-2 drug Vioxx from the market after a study linked it to increased risk of a heart attack. Study Suggests Celebrex Isn’t Riskier Than Rival Pain Drugs 2016-11-13T05:00:00Z He is known for defending Vioxx which is reported to have caused at least 50,000 heart attacks and events before its withdrawal. The FDA now officially belongs to Big Pharma 2016-02-27T05:00:00Z A Merck clinical trial asking if Vioxx could also prevent colon cancer revealed that the drug increased the risk of heart attacks, and the company pulled it off the market in 2004. Celebrex Is Found to Be No Riskier for Hearts Than Other Pain Drugs 2016-11-13T05:00:00Z Vioxx was withdrawn from the market in 2004 after evidence showed it doubled the risk of heart attack and stroke. US drugmaker settles painkiller lawsuit for $830m - BBC News 2016-01-15T05:00:00Z The company still faces individual securities lawsuits tied to Vioxx. Drugmaker Merck says it is paying $830 million to resolve a class-action lawsuit involving the painkiller Vioxx, which was pulled from the market years ago 2016-01-15T05:00:00Z The painkiller Vioxx continues to cost Merck & Co., more than 11 years after the company yanked the drug from the market because it increased users’ risk of heart attacks and strokes. Merck to Pay $830 Million to Settle Vioxx Shareholder Suit 2016-01-16T05:00:00Z Lawyers involved in the Vioxx case said that legal ethicists reviewed the provision and approved it. Lawyers Jostle for Lead Position in Volkswagen Diesel Suits 2015-10-26T04:00:00Z He followed that with Cipro along with Vioxx, a now-recalled nonsteroidal anti-inflammatory, or NSAID. It pays to read the warnings when you open up a prescription 2015-08-03T04:00:00Z Federal officials accused the company of making false statements and illegally marketing Vioxx as a treatment for rheumatoid arthritis to increase sales. US drugmaker settles painkiller lawsuit for $830m - BBC News 2016-01-15T05:00:00Z Inc. removed Vioxx from the market in 2004 after evidence showed it doubled the risk of heart attack and stroke. Drugmaker Merck says it is paying $830 million to resolve a class-action lawsuit involving the painkiller Vioxx, which was pulled from the market years ago 2016-01-15T05:00:00Z Supreme Court ruled unanimously that investors didn’t wait too long to file the Vioxx securities lawsuits, as Merck had contested. Merck to Pay $830 Million to Settle Vioxx Shareholder Suit 2016-01-16T05:00:00Z That’s when Merck & Co Inc. pulled its blockbuster pain reliever Vioxx off the market because of links to heart attack and stroke. FDA updates heart warnings on popular pain relievers 2015-07-09T04:00:00Z Think of how Vioxx, Celebrex and other so called COX-2 inhibitors were pulled from the market a decade ago after researchers found they increased the chance of heart attacks. TeradataVoice: It's Not The Algorithms; It's The Information! 2015-01-15T05:00:00Z It still faced a number of individual lawsuits related to Vioxx. US drugmaker settles painkiller lawsuit for $830m - BBC News 2016-01-15T05:00:00Z The backlash against Vytorin was part of a distrust of drug companies that started with another Merck medicine, the painkiller Vioxx, which caused heart attacks and was withdrawn from the market. After Years Under Attack, Merck's Vytorin Proves Effective 2014-11-17T05:00:00Z Justice Department and state governments that the company deceived the government about the safety of Vioxx, and marketed it for uses not included in the prescribing label approved by the Food and Drug Administration. Merck to Pay $830 Million to Settle Vioxx Shareholder Suit 2016-01-16T05:00:00Z He played a prominent role in the Vioxx and Avandia affairs in the past. FDA Once Again Reaches Conclusions At Odds With Its Own Staff 2014-07-14T04:00:00Z He pointed to the case of Vioxx, a once-popular painkiller that Merck, its manufacturer, illegally promoted for rheumatoid arthritis before the drug was discovered to actually increase risks for heart attacks. FDA has free-speech, safety issues to weigh in review of ‘off-label’ drug marketing rules The plaintiffs alleged that after Merck disclosed the problems with Vioxx, its market capitalization shrunk by billions of dollars. Merck, Pfizer, HSBC could be big winners from shareholder case 2014-06-12T04:00:00Z The drugs emerged in the early 2000s and included once best-selling pain relievers such as Vioxx and Bextra. FDA Approves Generic Version of Painkiller Celebrex 2014-05-30T04:00:00Z Both sides agreed on a claims administrator: Patrick Juneau, a laid-back Louisiana lawyer and a veteran administrator of major settlement funds, including the one resulting from lawsuits over the painkilling drug Vioxx. How a Gulf Settlement That BP Once Hailed Became Its Target 2014-04-26T23:47:14Z Unfortunately, Vioxx was found to cause heart attacks and strokes in a small percentage of patients and was pulled from the market. IBM Unveils 5 Smart Technology Trends For The Next 5 Years 2013-12-17T05:06:00Z And a subsidiary of Merck was forced to plead guilty to state criminal charges in connection with the marketing of the drug Vioxx, although the parent escaped with a nonprosecution agreement. DealBook: For SAC, Indictment May Imperil Its Survival 2013-07-25T00:24:42Z Problems with data about high-profile drugs have led to scandals over the past decade, like one involving contentions that the number of heart attacks was underreported in research about the painkiller Vioxx. Breaking the Seal on Drug Research 2013-06-29T20:08:12Z Known in cardiology circles for his work improving the way heart attack patients are treated, he had also consulted for plaintiff’s in lawsuits regarding Merck’s withdrawn pain pill Vioxx. No More Secrets: Medtronic Shows How Open Science Might Work In The Real World 2013-06-19T15:31:00Z Long-term high-dose use of painkillers such as ibuprofen and diclofenac is “equally hazardous” in terms of heart attack risk as use of Vioxx, which was withdrawn due to its potential dangers, researchers said last week. High doses of common painkillers increase heart attack risks, study finds 2013-06-03T20:22:09Z Merck's Vioxx arthritis drug was recalled in 2004 after being linked to heart attacks and strokes, forcing Kim to defend controversial clinical trials of the pill that were conducted before his arrival. Merck veteran named research chief, after drug setbacks 2013-03-07T20:00:06Z The same is true of Vioxx, made by Merck, the painkiller that was withdrawn after it emerged eight years ago that it doubled the risk of a heart attack. Families face battle with GSK over dangerous diabetes drug 2013-01-29T21:04:00Z Research by Garret Fitzgerald at the University of Pennsylvania, who had a decade ago warned about the potential heart risks of the arthritis drugs Vioxx and Celebrex, seemed to show such an effect was possible. Why Merck's Niacin Failure Will Scare Drug Researchers 2012-12-20T19:11:09Z One of the most well-known scandals involved Vioxx being taken off the market in 2004 after Merck admitted it withheld information about known adverse risk of heart disease, resulting in tens of thousands of deaths. Doctors versus Big Pharma : is it justifiable to judge research by its authors? 2012-10-28T22:45:04.130Z One of the most notorious episodes of misconduct involved Merck's anti-inflammatory drug Vioxx, withdrawn in 2004 after the company persistently played down its risk of causing cardiovascular problems. GlaxoSmithKline's bribes are evidence that Big Pharma isn't working 2012-07-04T13:45:51Z Celebrex and Vioxx, which was made by Merck, brought in billions in sales almost as soon as they were introduced in the 1990s. In Documents on Pain Drug Celebrex, Signs of Doubt and Deception 2012-06-25T02:46:07Z Reinforcing that point, Durham asked Likover whether the doctor would ever put "eat like Skittles" on a Vioxx prescription. Former Astros Manager Testifies for Clemens 2012-06-01T01:32:58Z The size of this harm, which is larger than that documented for Vioxx, is small enough that it would be nearly impossible to detect in the studies that were required for approval. The FDA Is Faster. Now Let's Make It Safer 2012-05-16T21:25:14Z Perhaps the most well-known criticism of TV advertising of pharmaceuticals arose in 2004 when Merck withdrew the once heavily advertised painkiller Vioxx after studies showed it increased the risk of heart attacks and strokes. Prescriptions Blog: Drug Makers Dial Down TV Advertising 2012-02-02T23:27:05Z While still a graduate student, he co-authored one of the main studies that confirmed substantial patient risks from the news-making painkiller Vioxx. Well Blog: Doctor and Patient: A Web Campaign to Prevent Cancer 2011-12-08T16:49:05Z But the excitement skidded to a halt in 2004, when Merck withdrew Vioxx after studies linked it to an increased risk for heart attacks. In Documents on Pain Drug Celebrex, Signs of Doubt and Deception 2012-06-25T02:46:07Z Investors are also suing Merck, saying it played down the risks of Vioxx and cost them billions of dollars in stock value after the drug was removed from the market. Merck to Pay $950 Million Over Vioxx 2011-11-23T16:40:11Z The settlement also resolves claims brought by 43 state attorneys general over the company’s marketing and sales practices in connection with Vioxx, Merck officials said in their statement. Merck to Pay $950 Million, Plead Guilty in U.S. Vioxx Probe 2011-11-23T19:21:16Z Merck pled guilty to a misdemeanor charge and will pay a $321.6 million criminal fine for introducing the misbranded drug Vioxx into interstate commerce. Merck to pay $950 million to settle U.S. Vioxx charge 2011-11-23T07:21:20Z Although Vioxx is no longer on the market, this ongoing monitoring of Merck’s conduct is aimed to deter and detect similar conduct in the future. Merck Pleads Guilty and Pays $950 Million for Illegal Promotion of Vioxx 2011-11-22T21:27:07Z Pfizer officials said the memo appears to reflect discussions by some Pharmacia employees about both the Celebrex study and a similar study of Vioxx. In Documents on Pain Drug Celebrex, Signs of Doubt and Deception 2012-06-25T02:46:07Z The charge arose from Merck’s promotion of Vioxx to treat rheumatoid arthritis before the Food and Drug Administration approved it for that purpose in 2002. Merck to Pay $950 Million Over Vioxx 2011-11-23T16:40:11Z Before that approval, the company touted Vioxx to physicians for rheumatoid arthritis, prompting the FDA to send a warning letter on Sept. Merck to Pay $950 Million, Plead Guilty in U.S. Vioxx Probe 2011-11-23T19:21:16Z Inc. will pay $950 million to resolve criminal and civil charges that it illegally promoted the painkiller Vioxx, the Justice Department announced Tuesday. Merck to pay $950 million to settle Vioxx probe 2011-11-22T20:35:00Z The FDA approved Vioxx® for three indications in May 1999, but did not approve its use against rheumatoid arthritis until April 2002. Merck Pleads Guilty and Pays $950 Million for Illegal Promotion of Vioxx 2011-11-22T21:27:07Z It will also plead guilty to a misdemeanor charge that it marketed Vioxx as a treatment for rheumatoid arthritis before getting Food and Drug Administration approval. Gov?t says Merck will pay $950M to settle Vioxx probe, will plead guilty to marketing charge 2011-11-22T20:41:28Z The legislation was passed in the wake of several high-profile drug scandals, including the increased risks of heart attacks among those taking Vioxx, the painkiller that ultimately was withdrawn from the market. Prescriptions Blog: F.D.A. Is Urged to Issue More Alerts About Drug Risks 2011-11-15T17:04:45Z The company pulled Vioxx off the market in 2004 after a study found it posed an increased risk of heart attacks and strokes. Merck to Pay $950 Million, Plead Guilty in U.S. Vioxx Probe 2011-11-23T19:21:16Z He made his name at Merck leading the company’s legal defense against thousands of claims that its Vioxx painkiller drug caused heart attacks and strokes. Penn State Names Merck’s Frazier Head of Investigative Team 2011-11-11T21:18:29Z In the interim, for nearly three years, Merck promoted Vioxx® for rheumatoid arthritis, conduct for which it was admonished in an FDA warning letter issued in September 2001. Merck Pleads Guilty and Pays $950 Million for Illegal Promotion of Vioxx 2011-11-22T21:27:07Z Vioxx was approved by the FDA in May 1999, but the government did not initially approve the drug for use in rheumatoid arthritis. Gov?t says Merck will pay $950M to settle Vioxx probe, will plead guilty to marketing charge 2011-11-22T20:41:28Z Litigation over its Vioxx painkiller, which tens of thousands of consumers said caused heart attacks, strokes or other problems, was a prime example of the bellwether system at work. Analysis: Corporate defendants rack up wins in "test" trials 2011-10-31T16:26:39Z The charge also cites eight instances of sales representatives recording in their notes of calls to physicians how they promoted Vioxx for rheumatoid arthritis. Merck to Pay $950 Million, Plead Guilty in U.S. Vioxx Probe 2011-11-23T19:21:16Z In one well-known example, the FDA-approved painkiller Vioxx was pulled off the market in 2004 after longer-term evidence showed that it may increase the risk of heart attack and stroke. Misunderstanding of drug approval common: study 2011-09-12T21:21:26Z He doubts the cost of the bladder cancer litigation will hit the level of Vioxx. Lawsuits follow diabetes drug link to cancer risk 2011-08-05T22:46:03Z The Justice Department said Merck promoted Vioxx for rheumatoid arthritis for three years and continued to do so after getting an FDA warning letter in September 2001. Gov?t says Merck will pay $950M to settle Vioxx probe, will plead guilty to marketing charge 2011-11-22T20:41:28Z The lead counsel for Merck in the Vioxx litigation, Philip Beck of law firm Bartlit Beck, acknowledged that defendants in test trials have fared better than plaintiffs in recent years. Analysis: Corporate defendants rack up wins in "test" trials 2011-10-31T16:26:39Z The company won 11 of 16 Vioxx lawsuits at trial before agreeing in 2007 to create the $4.85 billion settlement fund. Merck to Pay $950 Million, Plead Guilty in U.S. Vioxx Probe 2011-11-23T19:21:16Z Ghostwritten articles about Vioxx, which was later withdrawn amid safety concerns, had minimal input from guest authors. Scientists credited on ghostwritten articles 'should be charged with fraud' 2011-08-02T21:00:00Z Take the notorious Advantage study, a seeding trial of the pain reliever Vioxx conducted by Merck. Op-Ed Contributor: Useless Studies, Real Harm 2011-07-29T04:18:02Z To this we owe a the creation of powerful cholesterol and blood-pressure drugs that combat heart disease, and also the dawning realization that some medicines, like Vioxx, Avandia, and Baycol carried their own risks. Nicotine Addiction And The Birth Of Modern Medicine 2011-06-21T15:58:29Z Some company officials were worried that the costs of the Vioxx lawsuits might top $10 billion and push the company to the brink of bankruptcy, Mr. Schwartz said. But Nobody Pays That: Companies Push for Tax Break on Foreign Cash 2011-06-20T01:55:41Z Prosecutors in her office led the seven-year investigation into the company’s Vioxx marketing tactics. Merck to Pay $950 Million, Plead Guilty in U.S. Vioxx Probe 2011-11-23T19:21:16Z We need only look to conflicting findings about beta-carotene, vitamin E, hormone treatments, Vioxx and Avandia. An Epidemic of False Claims 2011-05-31T14:15:02.193Z Vioxx, which was pulled from the market in 2004 after research linked it to heart attacks and strokes. Novartis Aims to Resurrect ‘Zombie’ Drug in EU After Four Years 2011-04-06T05:45:44Z So I put in a call to the American lawyer Mark Lanier who represents the Vioxx claimants. The Epilim compensation case joins a dismal roll call 2011-02-01T18:35:50Z Public funding has been granted to one man who claims a drug called Vioxx caused him to have a stroke. No day in court? 2011-01-18T07:45:46Z The company will admit that between May 1999 and April 2002, it sold Vioxx for rheumatoid arthritis when it was not approved by the FDA for that use. Merck to Pay $950 Million, Plead Guilty in U.S. Vioxx Probe 2011-11-23T19:21:16Z Larry Long, debilitated by a stroke while using the pain medicine Vioxx, was facing eviction from his Georgia home in 2008. Lawsuit Loans Add New Risk for the Injured 2011-01-17T02:50:04Z In 2004, Vioxx, a COX-2 inhibitor, was withdrawn from the market after a trial showed it increased the risk of heart disease. Analysis shows heart, stroke risk of pain drugs 2011-01-12T00:02:08Z One of the American lawyers on Vioxx once told me that individual expert reports alone were running into "tens and 20s of thousands of dollars". The Epilim compensation case joins a dismal roll call 2011-02-01T18:35:50Z He too suffered a stroke which he believes was caused by Vioxx. No day in court? 2011-01-18T07:45:46Z The third group took another class of pain drugs called coxibs, which include Celebrex and Vioxx, a drug that is no longer on the market. Narcotic Painkillers May Pose Danger to Elderly Patients, Study Says 2010-12-14T05:40:04Z The maker of Vioxx, Merck, had already agreed to settle the Vioxx class action. Lawsuit Loans Add New Risk for the Injured 2011-01-17T02:50:04Z According to a commentary in Slate, drug reps continued to market Vioxx and doctors continued to prescribe it until Merck voluntarily pulled it from the market in 2004. More rules are needed to curb drug firms' attempts to influence physicians 2010-11-15T19:52:00Z On BBC Radio 4's File on 4 there was an excellent investigation comparing the failure of Epilim and Vioxx litigants in the UK with the progress of their American counterparts. The Epilim compensation case joins a dismal roll call 2011-02-01T18:35:50Z Avandia for diabetes and the painkiller Vioxx were both found to have safety problems that published studies had not shown up. Antidepressant reboxetine no better than a placebo, study finds 2010-10-12T23:02:00Z The agency also plans to install a surveillance system by 2012 that periodically scans 100 million anonymous electronic medical records for adverse drug effects; experts say this might have detected Vioxx's problems years earlier. Overmedication: Are Americans Taking Too Many Drugs? 2010-10-07T13:00:00Z But Gary Chodes, the company’s chief executive, said the performance of the Vioxx loans showed why Oasis must charge high rates. Lawsuit Loans Add New Risk for the Injured 2011-01-17T02:50:04Z And some, including Vioxx and Bextra, were taken off the market after they were linked to heart attacks and strokes. Topical Gel Catches Up With Pills for Relief 2010-09-06T18:21:00Z Vioxx doubled the risk of heart attacks and strokes, including fatal ones. Merck being probed for possibly violating anti-bribery laws 2010-08-10T04:00:00Z The legacy of Vioxx and the political firestorm that followed will hang over next week's deliberations. FDA review spotlights heart risk of diabetes pill 2010-07-10T13:16:00Z A known whistleblower, Graham has drawn attention to a number of other prescription drugs since the 2004 withdrawal of Merck & Co Inc's Vioxx. Glaxo's Avandia increases heart risks: U.S. reviewer 2010-06-11T19:22:00Z The company waived its claim against the Longs after the couple complained to the federal judge overseeing the Vioxx case. Lawsuit Loans Add New Risk for the Injured 2011-01-17T02:50:04Z “The turning point for topical Nsaids was the fright over heart problems with Vioxx,” Dr. Moore said. Topical Gel Catches Up With Pills for Relief 2010-09-06T18:21:00Z As an example, he mentioned the painkiller Vioxx, which Merck withdrew in 2004 after it became clear that it caused heart attacks and wasn't better than older drugs. Even good evidence needs promotion 2010-05-24T21:29:00Z They have represented Ecuadoran shrimp farmers and New York lobstermen, patients who have swallowed Vioxx and investors who lost money on shares of Enron. Lawyers lining up for class-action suits over oil spill 2010-05-17T04:00:00Z After bleeding was discovered, I was taken off ibuprofen and put on Vioxx, which at the time was thought to be less harsh on the stomach than other Nsaids. When Pain Relievers Cause Bleeding 2010-04-23T14:45:00Z Lenders pay lawyers to screen cases, looking for slam-dunks like Vioxx. Lawsuit Loans Add New Risk for the Injured 2011-01-17T02:50:04Z So, does the agreement constitute a solid bulwark, protecting investors and consumers against the possibility of another Vioxx? Slipstream: Does Merck Agreement Pave a Road Toward Change? 2010-04-03T22:23:00Z He had tried all sorts of drugs, from Vioxx to epidural steroids, but found little success. Marijuana use by seniors goes up as boomers age 2010-02-22T13:08:00Z Because it works the same way Vioxx does, the FDA refused to approve it in the U.S. in 2007. 2010-01-14T19:03:00Z But plaintiffs’ attorneys in some of the Vioxx jury trials contended that corporate changes made at Merck in the 1990s put the bottom line ahead of science or the company’s larger social responsibilities. Slipstream: Does Merck Agreement Pave a Road Toward Change? 2010-04-03T22:23:00Z When they did a study of Vioxx during Yom Kippur in September 2004, they saw similar results to those in the current report. 2010-01-14T19:03:00Z In analyzing the Vioxx crisis in the book “Judgment: How Winning Leaders Make Great Calls,” Mr. Tichy and a co-author take the Merck board to task for hiring a new C.E.O., Slipstream: Does Merck Agreement Pave a Road Toward Change? 2010-04-03T22:23:00Z Drescher said that with the risks of Vioxx in mind, the researchers were careful to only include healthy non-elderly people in their study. 2010-01-14T19:03:00Z |
| 随便看 |
英语例句辞典收录了117811条英语例句在线翻译词条，基本涵盖了全部常用单词及词组的例句翻译及用法，是英语学习的有利工具。